BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18491963)

  • 1. Hallucinations during voriconazole therapy.
    Zonios DI; Gea-Banacloche J; Childs R; Bennett JE
    Clin Infect Dis; 2008 Jul; 47(1):e7-e10. PubMed ID: 18491963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole-induced musical hallucinations.
    Agrawal AK; Sherman LK
    Infection; 2004 Oct; 32(5):293-5. PubMed ID: 15624894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complex visual hallucinations induced by voriconazole].
    Fernández-Ruiz M; López-Medrano F; Gutiérrez E; Aguado JM
    Med Clin (Barc); 2009 Jun; 133(4):156-7. PubMed ID: 19540418
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hallucinosis as side effect of voriconazole].
    Flox Benítez G; Rondón Fernández P; Quero Escalada M; Fernández Ballesteros A
    Rev Clin Esp; 2005 Dec; 205(12):632-3. PubMed ID: 16527191
    [No Abstract]   [Full Text] [Related]  

  • 5. Voriconazole toxicity related to polymorphisms in CYP2C19.
    Suan D; O'Connor K; Booth DR; Liddle C; Stewart GJ
    Intern Med J; 2011 Apr; 41(4):364-5. PubMed ID: 21507170
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
    J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
    Pea F; Viale P
    Ther Drug Monit; 2009 Feb; 31(1):135-6. PubMed ID: 19077926
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.
    Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Ishida T; Tanaka T
    Int J Hematol; 2008 Jul; 88(1):3-6. PubMed ID: 18574651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
    Imhof A; Schaer DJ; Schanz U; Schwarz U
    Swiss Med Wkly; 2006 Nov; 136(45-46):739-42. PubMed ID: 17183438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole-induced neuropathy.
    Aksoy F; Akdogan E; Aydin K; Yilmaz M; Altunayoglu V; Sozen EE; Omay SB; Koksal I
    Chemotherapy; 2008; 54(3):224-7. PubMed ID: 18560230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of cross-hepatotoxicity between voriconazole and posaconazole.
    Foo H; Gottlieb T
    Clin Infect Dis; 2007 Sep; 45(6):803-5. PubMed ID: 17712772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Voriconazole-associated phototoxicity].
    Serra Soler G; Delgado Sánchez O; Esteban Marcos E; Martínez-López I; Femenías Sureda M
    Farm Hosp; 2006; 30(6):386-7. PubMed ID: 17298198
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
    Pakyz A; Bearman G
    Consult Pharm; 2008 Oct; 23(10):804-8. PubMed ID: 19032016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
    González Rozas M; Alvarez Tundidor S; Pineda Alonso M
    Nefrologia; 2011; 31(1):112-3. PubMed ID: 21270925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Voriconazole safety: short review of clinical data].
    Veselov AV; Belousov DIu
    Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
    J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.